Home Page

About Us

Investors

Inventors

Portfolio

Contact Us

Privacy Policy

About Us

MetaCyte Business Lab, a for-profit subsidiary of the UofL Foundation, is a unique and vibrant health and life science incubator.

Working with the UofL Office of Technology Transfer and Nucleus, MetaCyte is creating a seamless commercialization process that will yield viable, operating companies with a combined value in excess of $1B by 2020.

In partnership with the inventor and co-founder, MetaCyte creates, launches, and manages portfolio companies, acquiring an equity position in each. By avoiding a fee-for-service model, precious capital is freed up and directed to company growth.

MetaCyte's team of management and industry experts gives MetaCyte portfolio companies a competitive advantage. The MetaCyte staff serves as a developing company's management team, focused on meeting early development milestones and fundraising, while the scientific co-founder focuses on research and development.

Since 2002, MetaCyte staff has secured more than $16M in funding for its portfolio companies, which has created in excess of 40 high-paying jobs, and returned more than $11M to UofL for additional research.

Working with the UofL Office of Technology Transfer and Nucleus, MetaCyte's goal is to transform life science discoveries and inventions from the mind to the marketplace to improve the physical and economic health of the Commonwealth of Kentucky.






July 16, 2010
Intrepid Bioinformatics Receives Investment, Meets Milestones

May 6, 2010
MetaCyte Business Lab Receives Mention in Nature (PDF)

March 31, 2010
MetaCyte Recognized for Innovation

March 15, 2010
Teresa Leezer Honored a Second Time for Excellence in Business Management

February 23, 2010
Gailar Addresses Leaders as Part of Innovation Panel

January 2010
Triathlon Medical Ventures and the Kentucky Seed Capital Fund Lead Investment in Louisville Start-Up

November 2009
MetaCyte Advisor Bill Strench Featured in Business First (External Link)

November 2009
EndoProtech Awarded $270,000 from Kentucky Cabinet for Economic Development

August 25, 2009
Pierce Named Interim Head of UofL Research (External Link)

July 1, 2009
AllTranz Named Top Innovator by National Venture Group

May 8, 2009
ApoImmune Finalist for "Best Early-Stage Vaccine Biotech" at World Vaccine Congress ViE Awards

September 12, 2008
MetaCyte Team Shows Off New Offices

June 18, 2008
Teresa Leezer Honored by Cambridge Who's Who for Excellence in Business Management

Summer 2006
A UofL research team led by Fred Roisen, Ph.D., has developed a breakthrough adult stem-cell therapy that repairs spinal-cord damage in paralyzed rats (External Link)